Antiviral activity of recombinant cyanovirin-N against HSV-1. (Q42759444)

6 November 2017

Antiviral activity of recombinant cyanovirin-N against HSV-1. (English)

1 reference

6 November 2017

Hong Yu

1

1 reference

6 November 2017

Zong-tao Liu

series ordinal

2

1 reference

6 November 2017

Rui Lv

series ordinal

3

1 reference

6 November 2017

Wen-qing Zhang

series ordinal

4

1 reference

6 November 2017

21 December 2010

1 reference

6 November 2017

1 reference

6 November 2017

25

1 reference

6 November 2017

6

1 reference

6 November 2017

432-439

1 reference

https://scigraph.springernature.com/pub.10.1007/s12250-010-3131-3

6 November 2017

0 references

cites work

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Solution structure of cyanovirin-N, a potent HIV-inactivating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Herpes simplex virus (HSV) pneumonia in a heart transplant: diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Antiviral drugs in current clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Relation between herpes simplex viruses and human immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3131-3

Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21221922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21221922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21221922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12250-010-3131-3

1 reference

6 November 2017

1 reference